The Fanconi Cancer Foundation (FCF) is excited to announce that Dr. Isis Sroka has been named CEO effective August 1, 2024. She succeeds Mark Quinlan who served as Executive Director since 2017 and recently announced his departure. Quinlan will continue in an advisory role with FCF through a transition period.
Announcements, Uncategorized
On May 24th, 2024, the FA Europe Network hosted its inaugural pan-European scientific meeting at the historic Saint-Louis Hospital in Paris, marking a significant milestone in international collaboration for Fanconi anemia (FA).
Announcements, Uncategorized
Dr. Velleuer with colleagues Mona and Christine, and Bella, who lives with FA
Uncategorized
My work Recently I became a principal investigator at UNAM, the leading University of Mexico. I maintain a strong interest in studying FA using additional and new technologies, including single cell DNA sequencing, single cell proteomics and single cell imaging....
Uncategorized
In recent years, much of FARF-funded research has focused on ways to prevent and detect cancer, and to develop less toxic therapies to improve and extend lives. As the research expanded, so did our approach to addressing this critical need....
Uncategorized
In November 2021,31 scientists came together for a five-day series of virtual workshops to brainstorm ideas to shift the paradigm for treating Fanconi anemia (FA) cancer. During these workshops, scientists formed interdisciplinary research teams and pitched their ideas regarding FA...
Uncategorized
